Dr. William G. Wierda, MD, PhD

  • Houston, TX
  • Hematologist and oncologist
NPI1497848279PAC ID0840488151
Medicare services, 2024
789
Medicare patients, 2024
268
Part D claims, 2024
249
Publications
556
Clinical trials
22
Practice address
1515 Holcombe Blvd, Houston, TX 77030
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Find Dr. Wierda's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. William G. Wierda is a hematologist and oncologist in Houston, Texas

Dr. Wierda practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Wierda's NPI, 1497848279, was assigned on October 2, 2006. Dr. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993. Dr. Wierda's Texas license number on file is L3873.

NPI and contact details
Medicare PAC ID
0840488151
NPI enumeration date
October 2, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
59
Medical school graduation
1993

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. William G. Wierda practices at The University of Texas MD Anderson Cancer Center in Houston, Texas

Dr. Wierda's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Source: Dmand AI Affiliation Data

Dr. William G. Wierda is affiliated with 1 site of care and 1 medical group

Dr. Wierda's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. William G. Wierda's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wierda practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The University of Texas MD Anderson Cancer CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Wierda practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. William G. Wierda is one of 814 hematologists and oncologists in Texas

Hematology and oncology is Dr. Wierda's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Wierda's licenses on file in 5 states: Texas, Florida, California, Oklahoma and North Carolina.

Specialties and state licenses

  • Hematology and oncology, TexasPrimaryLicense L3873 · 2002 to 2025 · taxonomy 207RH0003X
  • Florida licenseSince 2021
  • California license1996 to 2025
  • Oklahoma license2020 to 2021
  • North Carolina license1993 to 1999

Clinical focus

Dmand AI lists anemia, chronic anemia, chronic leukemia, immune deficiency disease and lymphoma among the conditions Dr. Wierda treats.

Hematologists and oncologists near Dr. Wierda

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. William G. Wierda billed Medicare for 789 services in 2024

CMS data shows 789 Medicare services from Dr. Wierda across 5 procedure codes in 2024, for 268 Medicare patients. Medicare paid $78,513 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024789
Medicare patients268
Paid by Medicare$78,513
Procedure codes5

Dr. Wierda's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 7282024: 7898%

Dr. Wierda compared with the Texas median for hematologists and oncologists, 2024

  • Dr. Wierda
  • Texas median
Medicare services
789vs 1,16232% below
Medicare patients
268vs 2517% above
Part D claims
120vs 48975% below

Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Wierda's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Wierda

Need commercial claims for Dr. Wierda?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wierda and other hematologists and oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. William G. Wierda treated 268 Medicare patients in 2024, average age 74

CMS counts 268 Medicare patients who saw Dr. Wierda in 2024. The largest group is 65 to 74, with 127 patients. 73% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wierda's median patient age at 72, with 47% women.

Medicare patients, 2024268
Average age74
Average risk score2.33

Dr. Wierda's Medicare patients by age, 2024

Dr. Wierda's Medicare patients by sex, 2024

  • Women10539%
  • Men16361%

Chronic conditions among Dr. Wierda's Medicare patients, 2024

  1. High blood pressure73%
  2. High cholesterol72%
  3. Arthritis45%
  4. Ischemic heart disease29%
  5. Chronic kidney disease28%
  6. Anxiety26%
  7. Atrial fibrillation25%
  8. Mood disorders24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Wierda's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women47%
  • Men52%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. William G. Wierda wrote 249 Medicare Part D claims in 2024

In 2024, Dr. Wierda wrote 249 Medicare Part D claims for 86 patients. 75% of them were for generic drugs. CMS names the drug for 120 of them, across 6 drugs with 11 or more claims each, at $570,359 in total drug cost. In 2023, CMS named 138 claims across 5 drugs.

Part D claims, 2024249
Drugs named by CMS6
Total drug cost$570,359
Part D patients86

Dr. Wierda's Part D claims by kind of drug, 2024

  • Generic186 claims75%
  • Brand-name63 claims25%

Dr. Wierda's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Wierda's Part D claims, 2024

  • Antibiotics22%54 of 249 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1382024: 12013%

Drugs named by CMS: 6 in 2024, 5 in 2023.

See all prescribing by Dr. Wierda

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. William G. Wierda scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wierda for performance year 2024, reported as part of a group. Dr. Wierda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Wierda's MIPS scores, performance year 2024

  • 84of 100Final score
  • 70.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 68of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Wierda by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. William G. Wierda has 556 publications on record

Dmand AI links 556 papers to Dr. Wierda, published from 2003 to 2025. 2017 was the busiest year, with 58. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Wierda has published most often in Blood. Dr. Wierda's most frequent co-authors are Michael J. Keating, MD, Susan M. O'Brien, MD and Hagop M. Kantarjian, MD.

Papers556
Years published2003 to 2025

Dr. Wierda's papers by year, 2016 to 2025

Topics Dr. Wierda writes about most

  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Antineoplastic Combined Chemotherapy Protocols
  • Antineoplastic Agents
  • Pyrimidines
  • Antibodies, Monoclonal
  • Rituximab
  • Protein Kinase Inhibitors
  • Piperidines

Dr. Wierda's most frequent co-authors

Recent publications by Dr. Wierda

See all 556 publications and co-authors

See who Dr. Wierda researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wierda works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. William G. Wierda has worked on 22 clinical trials

Dmand AI links Dr. Wierda to 22 clinical trials, 11 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Hematologic Neoplasms. M.D. Anderson Cancer Center sponsors the most, 15.

Clinical trials with Dr. Wierda by phase

  1. 8Phase 1: 8 trials
  2. 3Phase 1/2: 3 trials
  3. 11Phase 2: 11 trials
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Wierda's trials

  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, B-Cell
  • Hematologic Neoplasms
  • Jacobs syndrome
  • Leukemia, Prolymphocytic

Investigators on the most trials with Dr. Wierda

Recent clinical trials with Dr. Wierda

See all 22 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. William G. Wierda received $124,245 in industry payments from 2016 to 2025

CMS Open Payments shows 265 general payments to Dr. Wierda from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 82% of the total. Abbvie Inc. paid the most, $72,901. It also lists 15 research payments totaling $39,254 from 2016 to 2020.

General payments to Dr. Wierda by program year, 2016 to 2025

General payments to Dr. Wierda by kind, 2016 to 2025

$124.2Kin total
  • Travel and lodging$101,94082%
  • Speaker and faculty fees$12,04010%
  • Food and beverage$8,1857%
  • Honoraria$2,0002%
  • Consulting fees$790%

Companies that paid Dr. Wierda the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Wierda

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. William G. Wierda's committees and leadership roles

Dr. Wierda's committees and leadership roles

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas Version 3.2016Panel Member
2016

Source: Dmand AI Professional Profile Data

Dr. William G. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science

Dr. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993.

  1. Medical schoolChicago Medical School at Rosalind Franklin University of Medicine and Science

Source: Dmand AI Professional Profile Data

Dr. William G. Wierda accepts plans from 9 insurance carriers

Dr. Wierda is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.

  • Aetna
  • Excellus BlueCross BlueShield
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Elevance
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • CMS Medicare
  • +1 more carriersWith a free account

Plan types Dr. Wierda accepts, by number of carriers

  1. PPO6
  2. Medicare5
  3. POS5
  4. HMO4
  5. EPO3

Source: Dmand AI Insurance Network Data

Sources for Dr. William G. Wierda's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. William G. Wierda

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. William G. Wierda's NPI number?

Dr. William G. Wierda's NPI number is 1497848279. It was assigned on October 2, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. William G. Wierda?

Dr. William G. Wierda is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. William G. Wierda practice?

Dr. Wierda practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Wierda's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

What is Dr. William G. Wierda's medical license number?

Dr. Wierda's Texas license number on file is L3873, one of the licenses on file in 5 states.

Which states has Dr. William G. Wierda been licensed in?

Dmand AI has state licenses on file for Dr. Wierda in Texas (2002 to 2025), Florida (since 2021), California (1996 to 2025), Oklahoma (2020 to 2021) and North Carolina (1993 to 1999).

Which hospitals is Dr. William G. Wierda affiliated with?

Dr. Wierda practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.

What medical group is Dr. William G. Wierda part of?

Dr. Wierda is linked to Physicians Referral Service.

Does Dr. William G. Wierda accept Medicare?

Yes. CMS data shows Dr. Wierda billed Medicare for 789 services in 2024, and Dr. Wierda accepts Medicare assignment.

What is Dr. William G. Wierda's MIPS score?

Dr. Wierda's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

How many Medicare patients does Dr. William G. Wierda see?

CMS counts 268 Medicare patients who saw Dr. Wierda in 2024, with an average age of 74.

Show 8 more questionsShow fewer questions

What services does Dr. William G. Wierda bill to Medicare?

In 2024, Dr. Wierda's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and office visit, established patient (99214).

Where did Dr. William G. Wierda go to medical school?

Dr. Wierda graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1993.

What drugs does Dr. William G. Wierda prescribe most?

In 2024 Medicare Part D data, Dr. Wierda's most prescribed drugs by claims were Venclexta, Valacyclovir and Calquence.

Has Dr. William G. Wierda received payments from drug or device companies?

CMS Open Payments shows $124,245 in general payments to Dr. Wierda from 17 companies from 2016 to 2025. The largest total came from Abbvie Inc.

How long has Dr. William G. Wierda been practicing?

Dr. Wierda graduated from medical school in 1993, 33 years ago.

Does Dr. William G. Wierda do research?

Dmand AI links 556 publications to Dr. Wierda, published from 2003 to 2025. Dr. Wierda has worked on 22 clinical trials.

Who does Dr. William G. Wierda publish with?

Dr. Wierda's most frequent co-authors are Michael J. Keating, MD (244 shared papers), Susan M. O'Brien, MD (180 shared papers) and Hagop M. Kantarjian, MD (165 shared papers).

What insurance does Dr. William G. Wierda accept?

Dr. Wierda is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)